Ramesh Poluru
INCLEN Trust International(IN)
Publications by Year
Research Areas
Climate Change and Health Impacts, Vaccine Coverage and Hesitancy, Global Health Care Issues, Global Public Health Policies and Epidemiology, Sepsis Diagnosis and Treatment
Most-Cited Works
- → Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the referral is not feasible in Palwal district of Haryana, India(2021)25 cited
- → Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis(2020)21 cited
- → Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0–2-month-old low birth weight infants in India—the “ProSPoNS” Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial(2021)13 cited
- Contact with HIV prevention programmes & willingness for new interventions among truckers in India.(2013)
- → Patterns of condom use by men who have sex with men before and after the Avahan intervention in Andhra Pradesh state of India(2014)12 cited
- → WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization(2021)9 cited
- → A Prospective Cohort Study on the Safety of Infant Pentavalent (DTwP-HBV-Hib) and Oral Polio Vaccines in Two South Indian Districts(2020)8 cited
- → Transparent Reporting of Pediatric Clinical Trial Interventions: TIDieR-Children and Adolescents(2025)8 cited
- → Cost of treating sick young infants (0-59 days) with Possible Serious Bacterial Infection in resource-constrained outpatient primary care facilities: An insight from implementation research in two districts of Haryana and Uttar Pradesh (India)(2023)5 cited
- → Study protocol for economic evaluation of probiotic intervention for prevention of neonatal sepsis in 0–2-month old low-birth weight infants in India: the ProSPoNS trial(2023)4 cited